[1]
|
Linden, J., Koch-Nolte, F. and Dahl, G. (2019) Purine Release, Metabolism, and Signaling in the Inflammatory Response. Annual Review of Immunology, 37, 325-347. https://doi.org/10.1146/annurev-immunol-051116-052406
|
[2]
|
El Ridi, R. and Tallima, H. (2017) Physiological Functions and Pathogenic Potential of Uric Acid: A Review. Journal of Advanced Research, 8, 487-493. https://doi.org/10.1016/j.jare.2017.03.003
|
[3]
|
Zhang, S., et al. (2019) Hyperuricemia and Cardiovascular Disease. Current Pharmaceutical Design, 25, 700-709.
https://doi.org/10.2174/1381612825666190408122557
|
[4]
|
Yanai, H., Adachi, H., Hakoshima, M. and Katsuyama, H. (2021) Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease. International Journal of Molecular Sciences, 22, Article No. 9221.
https://doi.org/10.3390/ijms22179221
|
[5]
|
Dong, Z., et al. (2015) Association between ABCG2 Q141K Poly-morphism and Gout Risk Affected by Ethnicity and Gender: A Systematic Review and Meta-Analysis. International Journal of Rheumatic Diseases, 18, 382-391.
https://doi.org/10.1111/1756-185X.12519
|
[6]
|
Stiburkova, B., Pavelcova, K., Pavlikova, M., Ješina, P. and Pavelka, K. (2019) The Impact of Dysfunctional Variants of ABCG2 on Hyperuricemia and Gout in Pediatric-Onset Patients. Arthritis Research & Therapy, 21, Article No. 77.
https://doi.org/10.1186/s13075-019-1860-8
|
[7]
|
Eckenstaler, R. and Benndorf, R.A. (2021) The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update. International Journal of Molecular Sciences, 22, Article No. 6678.
https://doi.org/10.3390/ijms22136678
|
[8]
|
Latourte, A., Dumurgier, J., Paquet, C. and Richette, P. (20121) Hyperuricemia, Gout, and the Brain—An Update. Current Rheumatology Reports, 23, Article No. 82. https://doi.org/10.1007/s11926-021-01050-6
|
[9]
|
Danve, A., Sehra, S.T. and Neogi, T. (2021) Role of Diet in Hyperuricemia and Gout. Best Practice & Research Clinical Rheumatology, 35, Article ID: 101723. https://doi.org/10.1016/j.berh.2021.101723
|
[10]
|
Aihemaitijiang, S., et al. (2020) The Association between Pu-rine-Rich Food Intake and Hyperuricemia: A Cross-Sectional Study in Chinese Adult Residents. Nutrients, 12, Article No. 3835. https://doi.org/10.3390/nu12123835
|
[11]
|
White, J., et al. (2016) Plasma Urate Concentration and Risk of Coronary Heart Disease: A Mendelian Randomisation Analysis. The Lancet Diabetes and Endocrinology, 4, 327-336. https://doi.org/10.1016/S2213-8587(15)00386-1
|
[12]
|
Gill, D., et al. (2021) Urate, Blood Pressure, and Cardiovascular Disease: Evidence from Mendelian Randomization and Meta-Analysis of Clinical Trials. Hypertension, 77, 383-392.
https://doi.org/10.1161/HYPERTENSIONAHA.120.16547
|
[13]
|
Hong, M., et al. (2020) A Mendelian Randomi-zation Analysis: The Causal Association between Serum Uric Acid and Atrial Fibrillation. European Journal of Clinical Investigation, 50, e13300. https://doi.org/10.1111/eci.13300
|
[14]
|
Kleber, M.E., et al. (2015) Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. Journal of the American Society of Nephrology, 26, 2831-2838. https://doi.org/10.1681/ASN.2014070660
|
[15]
|
Holme, I., Aastveit, A.H., Hammar, N., Jungner, I. and Walldius, G. (2009) Uric Acid and Risk of Myocardial Infarction, Stroke and Congestive Heart Failure in 417,734 Men and Women in the Apolipoprotein MOrtality RISk Study (AMORIS). Journal of Internal Medicine, 266, 558-570. https://doi.org/10.1111/j.1365-2796.2009.02133.x
|
[16]
|
Bos, M.J., Koudstaal, P.J., Hofman, A., Witteman, J.C.M. and Breteler, M.M.B. (2006) Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study. Stroke, 37, 1503-1507.
https://doi.org/10.1161/01.STR.0000221716.55088.d4
|
[17]
|
Pugliese, N.R., et al. (2021) The Importance of In-cluding Uric Acid in the Definition of Metabolic Syndrome When Assessing the Mortality Risk. Clinical Research in Cardiology, 110, 1073-1082.
https://doi.org/10.1007/s00392-021-01815-0
|
[18]
|
Dyrbuś, M., et al. (2021) Serum Uric Acid Is an Independent Risk Factor of Worse Mid- and Long-Term Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes. Cardiology Journal, 2021, Article No. 0156.
https://doi.org/10.5603/CJ.a2021.0156
|
[19]
|
Saito, Y., Nakayama, T., Sugimoto, K., Fujimoto, Y. and Kobayashi, Y. (2015) Relation of Lipid Content of Coronary Plaque to Level of Serum Uric Acid. The American Journal of Cardiology, 116, 1346-1350.
https://doi.org/10.1016/j.amjcard.2015.07.059
|
[20]
|
许晶晶, 姜琳, 宋莹, 姚懿, 贾斯达, 刘越, 袁德山, 李天瑜, 陈珏, 吴元, 张峻, 陈纪林, 杨跃进, 高润霖, 乔树宾, 徐波, 袁晋青. 早发急性心肌梗死的影响因素及其PCI术后远期预后[J]. 中华心血管病杂志, 2020, 48(8): 655-660. https://doi.org/10.3760/cma.j.cn112148-20191208-00738
|
[21]
|
Casiglia, E., et al. (2020) Serum Uric Acid and Fatal Myocardial Infarction: Detection of Prognostic Cut-off Values: The URRAH (Uric Acid Right for Heart Health) Study. Journal of Hypertension, 38, 412-419.
https://doi.org/10.1097/HJH.0000000000002287
|
[22]
|
Efstathiadou, A., Gill, D., McGrane, F., Quinn, T. and Dawson, J. (2019) Genetically Determined Uric Acid and the Risk of Cardiovascular and Neurovascular Diseases: A Mendelian Randomization Study of Outcomes Investigated in Randomized Trials. Journal of the American Heart As-sociation, 8, e012738. https://doi.org/10.1161/JAHA.119.012738
|
[23]
|
Keenan, T., et al. (2016) Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases through a Mendelian Randomization Study. Journal of the American College of Cardiology, 67, 407-416.
https://doi.org/10.1016/j.jacc.2015.10.086
|
[24]
|
Zalawadiya, S.K., et al. (2015) Uric Acid and Cardiovascular Disease Risk Reclassification: Findings from NHANES III. European Journal of Preventive Cardiology, 22, 513-518. https://doi.org/10.1177/2047487313519346
|
[25]
|
Cicero, A.F., et al. (2017) Serum Uric Acid Change and Modi-fication of Blood Pressure and Fasting Plasma Glucose in an Overall Healthy Population Sample: Data from the Brisighella Heart Study. Annals of Medicine, 49, 275-282.
https://doi.org/10.1080/07853890.2016.1222451
|
[26]
|
Sung, K.-C., et al. (2017) Baseline and Change in Uric Acid Concentration Over Time Are Associated with Incident Hypertension in Large Korean Cohort. American Journal of Hypertension, 30, 42-50.
https://doi.org/10.1093/ajh/hpw091
|
[27]
|
Ma, H., et al. (2019) Distinct Uric Acid Trajectories Are Associated with Different Risks of Incident Hypertension in Middle-Aged Adults. Mayo Clinic Proceedings, 94, 611-619. https://doi.org/10.1016/j.mayocp.2018.08.042
|
[28]
|
Tian, X., et al. (2020) Associations between Changes in Serum Uric Acid and the Risk of Myocardial Infarction. International Journal of Cardiology, 314, 25-31. https://doi.org/10.1016/j.ijcard.2020.03.083
|
[29]
|
Kumar, N., Kumar, H., Kumar, V. and Nayyer, P.S. (2020) A Study of the Serum Uric Acid Level as Prognostic Indicator in Acute Myocardial Infarction. The Journal of the Asso-ciation of Physicians of India, 68, 31-34.
|
[30]
|
Hajizadeh, R., Ghaffari, S., Salehi, R., Mazani, S. and Aghavali, S. (2016) Association of Serum Uric Acid Level with Mortality and Morbidity of Patients with Acute ST-Elevation Myocardial Infarction. Journal of Cardiovascular and Thoracic Research, 8, 56-60. https://doi.org/10.15171/jcvtr.2016.11
|
[31]
|
Magnoni, M., et al. (2017) Serum Uric Acid on Admission Predicts In-Hospital Mortality in Patients with Acute Coronary Syndrome. International Journal of Cardiology, 240, 25-29. https://doi.org/10.1016/j.ijcard.2017.04.027
|
[32]
|
Kuźma, Ł., et al. (2020) The Effect of Serum Uric Acid Levels on the Long-Term Prognosis of Patients with Non-ST-Elevation Myocardial Infarction. Advances in Clinical and Ex-perimental Medicine, 29, 1255-1263.
https://doi.org/10.17219/acem/127145
|
[33]
|
Centola, M., et al. (2020) Impact of Admission Serum Acid Uric Levels on In-Hospital Outcomes in Patients with Acute Coronary Syndrome. European Journal of Internal Medicine, 82, 62-67.
https://doi.org/10.1016/j.ejim.2020.07.013
|
[34]
|
Guo, W., et al. (2019) Hyperuricemia and Long-Term Mortality in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Annals of Translational Medicine, 7, Article No. 636.
https://doi.org/10.21037/atm.2019.10.110
|
[35]
|
Kaya, M.G., et al. (2012) Prognostic Value of Uric Acid in Patients with ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention. The American Journal of Cardiology, 109, 486-491.
https://doi.org/10.1016/j.amjcard.2011.09.042
|
[36]
|
Levantesi, G., et al. (2013) Uric Acid: A Cardiovascular Risk Factor in Patients with Recent Myocardial Infarction. International Journal of Cardiology, 167, 262-269. https://doi.org/10.1016/j.ijcard.2011.12.110
|
[37]
|
Lazzeri, C., et al. (2010) Uric Acid in the Acute Phase of ST Elevation Myocardial Infarction Submitted to Primary PCI: Its Prognostic Role and Relation with Inflammatory Markers: A Single Center Experience. International Journal of Cardiology, 138, 206-209. https://doi.org/10.1016/j.ijcard.2008.06.024
|
[38]
|
Lazzeri, C., Valente, S., Chiostri, M., Picariello, C. and Gensini, G.F. (2012) Uric Acid in the Early Risk Stratification of ST-Elevation Myocardial Infarction. Internal and Emergency Medicine, 7, 33-39.
https://doi.org/10.1007/s11739-011-0515-9
|
[39]
|
Mora-Ramírez, M., Estevez-Garcia, I.O., Irigoyen-Camacho, M.E., Bojalil, R., González-Pacheco, H. and Amezcua-Guerra, L.M. (2017) Hyperuricemia on Admission Predicts Short-Term Mortality Due to Myocardial Infarction in a Population with High Prevalence of Cardiovascular Risk Factors. Revista de Investigación Clínica, 69, 247-253.
https://doi.org/10.24875/RIC.17002167
|
[40]
|
Mandurino-Mirizzi, A., et al. (2021) Elevated Serum Uric Acid Is Associated with a Greater Inflammatory Response and with Short- and Long-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Nutrition, Metabolism and Cardiovascular Diseases, 31, 608-614.
https://doi.org/10.1016/j.numecd.2020.10.020
|
[41]
|
严凌, 叶露, 汪坤, 周杰, 朱春甲. 阿托伐他汀可改善急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后无复流现象[J]. 浙江大学学报(医学版), 2016, 45(5): 530-535.
|
[42]
|
Mandurino-Mirizzi, A., et al. (2018) Elevated Serum Uric Acid Affects Myocardial Reperfusion and Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Journal of Cardiovascular Medicine, 19, 240-246. https://doi.org/10.2459/JCM.0000000000000634
|
[43]
|
Akpek, M., et al. (2011) The Association of Serum Uric Acid Levels on Coronary Flow in Patients with STEMI Undergoing Primary PCI. Atherosclerosis, 219, 334-341. https://doi.org/10.1016/j.atherosclerosis.2011.07.021
|
[44]
|
Wang, R., et al. (2017) Determination of Risk Factors Affecting the In-Hospital Prognosis of Patients with Acute ST Segment Elevation Myocardial Infarction after Percuta-neous Coronary Intervention. BMC Cardiovascular Disorders, 17, Article No. 243. https://doi.org/10.1186/s12872-017-0660-9
|
[45]
|
Hu, X., et al. (2022) Elevated Uric Acid Is Related to the No-/Slow-Reflow Phenomenon in STEMI Undergoing Primary PCI. European Journal of Clinical Investigation, 52, e13719. https://doi.org/10.1111/eci.13719
|
[46]
|
Masuda, M., et al. (2016) Clinical Impact of Ventricular Tachy-cardia and/or Fibrillation During the Acute Phase of Acute Myocardial Infarction on In-Hospital and 5-Year Mortality Rates in the Percutaneous Coronary Intervention Era. Circulation Journal, 80, 1539-1547. https://doi.org/10.1253/circj.CJ-16-0183
|
[47]
|
Watanabe, S. and Usui, M. (2021) Serum Uric Acid Level Is Asso-ciated with Reperfusion Ventricular Arrhythmias in Acute Myocardial Infarction. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15, Article ID: 102198.
https://doi.org/10.1016/j.dsx.2021.102198
|
[48]
|
Hu, X., Fu, S. and Wang, S. (2022) Hyperuricemia Is Associated with an Increased Prevalence of Ventricular Tachycardia and Fibrillation in Patients with ST-Elevation Myocardial In-farction after Primary Percutaneous Coronary Intervention. BMC Cardiovascular Disorders, 22, Article No. 199. https://doi.org/10.1186/s12872-022-02635-4
|
[49]
|
Kajana, V., et al. (2022) Serum Uric Acid in Patients with ST-Segment Elevation Myocardial Infarction: An Innocent Bystander or Leading Actor? Nutrition, Metabolism and Cardiovascular Diseases, 32, 1583-1589.
https://doi.org/10.1016/j.numecd.2022.03.023
|
[50]
|
Mazidi, M., Katsiki, N., Mikhailidis, D.P. and Banach, M. (2019) Association of Ideal Cardiovascular Health Metrics with Serum Uric Acid, Inflammation and Atherogenic Index of Plasma: A Population-Based Survey. Atherosclerosis, 284, 44-49. https://doi.org/10.1016/j.atherosclerosis.2018.09.016
|
[51]
|
Mandurino-Mirizzi, A., et al. (2020) Serum Uric Acid May Modulate the Inflammatory Response after Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction. Journal of Cardiovascular Medicine, 21, 337-339. https://doi.org/10.2459/JCM.0000000000000926
|
[52]
|
Machado, G.P., et al. (2018) Comparison of Neutro-phil-to-Lymphocyte Ratio and Mean Platelet Volume in the Prediction of Adverse Events after Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction. Atherosclerosis, 274, 212-217. https://doi.org/10.1016/j.atherosclerosis.2018.05.022
|
[53]
|
Toldo, S. and Abbate, A. (2018) The NLRP3 Inflammasome in Acute Myocardial Infarction. Nature Reviews Cardiology, 15, 203-214. https://doi.org/10.1038/nrcardio.2017.161
|
[54]
|
Dalbeth, N., Merriman, T.R. and Stamp, L.K. (2016) Gout. Lancet, 388, 2039-2052.
https://doi.org/10.1016/S0140-6736(16)00346-9
|
[55]
|
Gherghina, M.E., et al. (2022) Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment. International Journal of Molecular Sciences, 23, Article No. 3188. https://doi.org/10.3390/ijms23063188
|
[56]
|
Maruhashi, T., Hisatome, I., Kihara, Y. and Higashi, Y. (2018) Hyperuricemia and Endothelial Function: From Molecular Background to Clinical Perspectives. Atherosclerosis, 278, 226-231.
https://doi.org/10.1016/j.atherosclerosis.2018.10.007
|
[57]
|
Packer, M. (2020) Uric Acid Is a Biomarker of Oxida-tive Stress in the Failing Heart: Lessons Learned from Trials with Allopurinol and SGLT2 Inhibitors. Journal of Cardiac Failure, 26, 977-984.
https://doi.org/10.1016/j.cardfail.2020.08.015
|
[58]
|
Singh, J.A. (2015) When Gout Goes to the Heart: Does Gout Equal a Cardiovascular Disease Risk Factor? Annals of the Rheumatic Diseases, 74, 631-634. https://doi.org/10.1136/annrheumdis-2014-206432
|
[59]
|
Maloberti, A., et al. (2020) Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project. High Blood Pressure & Cardiovascular Prevention, 27, 121-128.
https://doi.org/10.1007/s40292-020-00368-z
|
[60]
|
Yasutake, Y., et al. (2017) Uric Acid Ameliorates Indometha-cin-Induced Enteropathy in Mice through Its Antioxidant Activity. Journal of Gastroenterology and Hepatology, 32, 1839-1845. https://doi.org/10.1111/jgh.13785
|
[61]
|
Johnson, R.J., et al. (2018) Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. American Journal of Kidney Diseases, 71, 851-865. https://doi.org/10.1053/j.ajkd.2017.12.009
|
[62]
|
Dai, Y., Cao, Y., Zhang, Z., Vallurupalli, S. and Mehta, J.L. (2017) Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation. Cardiovascular Drugs and Therapy, 31, 19-27.
https://doi.org/10.1007/s10557-016-6706-x
|
[63]
|
Kattoor, A.J., Kanuri, S.H. and Mehta, J.L. (2019) Role of Ox-LDL and LOX-1 in Atherogenesis. Current Medicinal Chemistry, 26, 1693-1700. https://doi.org/10.2174/0929867325666180508100950
|
[64]
|
Hisatome, I., et al. (2021) Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease—Japanese Guideline on the Management of Asymptomatic Hyperuricemia. Circulation Journal, 85, 130-138.
https://doi.org/10.1253/circj.CJ-20-0406
|
[65]
|
Doğru, S., Yaşar, E. and Yeşilkaya, A. (2022) Uric Acid Can En-hance MAPK Pathway-Mediated Proliferation in Rat Primary Vascular Smooth Muscle Cells via Controlling of Mito-chondria and Caspase-Dependent Cell Death. Journal of Receptors and Signal Transduction, 42, 293-301. https://doi.org/10.1080/10799893.2021.1931320
|
[66]
|
Li, H., Qian, F., Liu, H. and Zhang, Z. (2019) Elevated Uric Acid Levels Promote Vascular Smooth Muscle Cells (VSMC) Proliferation via an Nod-Like Receptor Protein 3 (NLRP3)-Inflammasome-Dependent Mechanism. Medical Science Monitor, 25, 8457-8464. https://doi.org/10.12659/MSM.916667
|
[67]
|
Zhang, J., Lin, X., Xu, J. and Tang, F. (2019) Apelin-13 Reduces Oxidative Stress Induced by Uric Acid via Downregulation of Renin-Angiotensin System in Adipose Tissue. Toxicology Letters, 305, 51-57.
https://doi.org/10.1016/j.toxlet.2019.01.014
|
[68]
|
Zhang, J.-X., Zhang, Y.-P., Wu, Q.-N. and Chen, B. (2015) Uric Acid Induces Oxidative Stress via an Activation of the Renin-Angiotensin System in 3T3-L1 Adipocytes. Endocrine, 48, 135-142. https://doi.org/10.1007/s12020-014-0239-5
|